Eliot Finkel Investment Counsel LLC Makes New $1.70 Million Investment in The Clorox Company $CLX

Eliot Finkel Investment Counsel LLC bought a new stake in The Clorox Company (NYSE:CLX) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 13,765 shares of the company’s stock, valued at approximately $1,697,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Total Investment Management Inc. bought a new position in Clorox during the 2nd quarter worth $25,000. American National Bank & Trust increased its position in Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after buying an additional 89 shares during the period. True Wealth Design LLC lifted its stake in Clorox by 1,020.0% in the third quarter. True Wealth Design LLC now owns 224 shares of the company’s stock valued at $28,000 after buying an additional 204 shares during the last quarter. NewSquare Capital LLC boosted its holdings in shares of Clorox by 567.6% during the second quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after acquiring an additional 193 shares during the period. Finally, Bank & Trust Co acquired a new position in shares of Clorox during the third quarter valued at $30,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Price Performance

Shares of NYSE:CLX opened at $106.20 on Monday. The stock has a market cap of $12.95 billion, a price-to-earnings ratio of 16.67, a PEG ratio of 0.53 and a beta of 0.58. The company has a debt-to-equity ratio of 18.01, a current ratio of 0.76 and a quick ratio of 0.50. The Clorox Company has a 12 month low of $96.66 and a 12 month high of $164.22. The stock’s 50 day moving average price is $103.00 and its 200 day moving average price is $115.60.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, November 3rd. The company reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The company had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter in the previous year, the business earned $1.86 EPS. The company’s quarterly revenue was down 18.9% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Equities research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be given a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, January 28th. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.7%. Clorox’s payout ratio is 77.86%.

Analysts Set New Price Targets

CLX has been the topic of a number of analyst reports. Bank of America dropped their price objective on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a report on Wednesday, October 8th. The Goldman Sachs Group dropped their price target on shares of Clorox from $110.00 to $94.00 and set a “sell” rating on the stock in a research note on Wednesday. Citigroup reduced their price objective on Clorox from $120.00 to $109.00 and set a “neutral” rating for the company in a research report on Wednesday, December 17th. Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. Finally, Cowen reaffirmed a “hold” rating on shares of Clorox in a research note on Thursday. One research analyst has rated the stock with a Buy rating, fourteen have assigned a Hold rating and four have given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average price target of $122.88.

Insiders Place Their Bets

In other news, Director Pierre R. Breber purchased 4,000 shares of the business’s stock in a transaction dated Friday, November 21st. The shares were acquired at an average price of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the acquisition, the director directly owned 13,000 shares of the company’s stock, valued at $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.63% of the company’s stock.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.